Publikationen von Hans Faber

Faber, H.; Kurtoic, D.; Krishnamoorthy, G.; Weber, P.; Puetz, B.; Mueller-Myhsok, B.; Weber, F.; Andlauer, T. F. M.: Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes. FRONTIERS IN IMMUNOLOGY 11, 2165 (2020)

Hoffmann, F. S.; Hofereiter, J.; Ruebsamen, H.; Melms, J.; Schwarz, S.; Faber, H.; Weber, P.; Pütz, B.; Loleit, V.; Weber, F. et al.; Hohlfeld, R.; Meinl, E.; Krumbholz, M.: Fingolimod induces neuroprotective factors in human astrocytes. JOURNAL OF NEUROINFLAMMATION 12, 184 (2015)

Nischwitz, S.; Faber, H.; Saemann, P. G.; Domingues, H. S.; Krishnamoorthy, G.; Knop, M.; Müller-Sarnowski, F.; Yassouridis, A.; Weber, F.: Interferon-1a reduces increased interleukin-16 levels in multiple sclerosis patients. ACTA NEUROLOGICA SCANDINAVICA 130 (1), S. 46 - 52 (2014)

Faber, H.; Fischer, H.-J.; Weber, F.: Prolonged and symptomatic bradycardia following a single dose of fingolimod. MULTIPLE SCLEROSIS JOURNAL 19 (1), S. 126 - 128 (2013)

Lill, C. M.; Liu, T.; Schjeide, B. M. M.; Roehr, J. T.; Akkad, D. A.; Damotte, V.; Alcina, A.; Ortiz, M. A.; Arroyo, R.; de Lapuente, A. L. et al.; Blaschke, P.; Winkelmann, A.; Gerdes, L. A.; Luessi, F.; Fernadez, O.; Izquierdo, G.; Antiguedad, A.; Hoffjan, S.; Cournu-Rebeix, I.; Gromöller, S.; Faber, H.; Liebsch, M.; Meissner, E.; Chanvillard, C.; Touze, E.; Pico, F.; Corcia, P.; Dorner, T.; Steinhagen-Thiessen, E.; Baeckman, L.; Heekeren, H. R.; Li, S. C.; Lindenberger, U.; Chan, A.; Hartung, H. P.; Aktas, O.; Lohse, P.; Kümpfel, T.; Kubisch, C.; Epplen, J. T.; Zettl, U. K.; Fontaine, B.; Vandenbroeck, K.; Matesanz, F.; Urcelay, E.; Bertram, L.; Zipp, F.: Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. Journal of Medical Genetics 49 (9), S. 558 - 562 (2012)

Hahn, F.; Faber, H.; Weber, P.; Pütz, B.; Knop, M.; Nischwitz, S.; Weber, F.: Methylprednisolone-regulated genes affecting multiple sclerosis pathogenesis. Journal of Neurology 259 (Suppl. 1), S. S13 - S13 (2012)

Havla, J.; Gerdes, L. A.; Meinl, I.; Krumbholz, M.; Faber, H.; Weber, F.; Pellkofer, H. L.; Hohlfeld, R.; Kümpfel, T.: De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology 258 (9), S. 1665 - 1669 (2011)

Nischwitz, S.; Sämann, P. G.; Knop, M.; Müller-Sarnowski, F.; Faber, H.; Yassouridis, A.; Weber, F.: Modulation of interleukin-16 by interferon beta-1a treatment in patients with multiple sclerosis. Journal of Neurology 257 (Suppl. 1), S. S218 - S219 (2010)

Knop, M.; Vargas-Leal, V.; Faber, H.; Lutz, S.; Müller-Sarnowski, F.; Hornung, J.; Turck, C. W.; Weber, F.: Prohibitin: prohibiting inflammation in glatiramer acetate-treated multiple sclerosis patients? Multiple Sclerosis 14 (Suppl. 1), S. S132 - S132 (2008)

Faber, H.; Leistner, S.; Ising, M.: Cross-sectional study in German MS patients reveals unmet needs with regard to psychiatric comorbidity. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, FRANCE, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL 23 (3, Suppl.), P883, S. 457 - 457 (2017)

Faber, H.; Rampp, C.; Wollweber, B.; Uhr, M.; Beitinger, P. A.: Cerebrospinal fluid suggestive of central nervous system autoimmunity in a young woman with PTEN-related Cowden syndrome. In EUROPEAN JOURNAL OF NEUROLOGY, 22 (Supplement 1 SI), S. 786 - 786. Wiley-Blackwell, Hoboken, NJ, USA (2015)

Faber, H.; Krishnamoorthy, G.; Domingues, H. S.; Weber, P.; Pütz, B.; Weber, F.: Role of nuclear receptors in differentiation of MOG-specific Th17 cells and MOG-induced experimental autoimmune encephalomyelitis. In SI, 275 (1-2), 295, S. 198 - 199. 12th International Congress of Neuroimmunology (ISNI), Mainz, GERMANY, 09. November 2014 - 13. November 2014. (2014)

Faber, H.; Krishnamoorthy, G.; Weber, P.; Puetz, B.; Weber, F.: Spontaneous and induced experimental autoimmune encephalomyelitis (EAE) models in mice culminate in common pathways. In MULTIPLE SCLEROSIS JOURNAL, 19 (11), S. 9 - 10. 29th Congress of the European-Committee-for-Treatment-and Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS. (2013)

Hoffmann, F.; Hofereiter, J.; Ruebsamen, H.; Faber, H.; Weber, P.; Pütz, B.; Weber, F.; Hohlfeld, R.; Meinl, E.; Krumbholz, M.: Effects of fingolimod treatment on astrocyte functions. In MULTIPLE SCLEROSIS JOURNAL, 19 (11), S. 241 - 242. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, DENMARK, 02. Oktober 2013 - 05. Oktober 2013. (2013)

Knop, M.; Kirmeier, T.; Faber, H.; Nischwitz, S.; Turck, C.; Weber, F.: Glatiramer Acetate Induced Intracellular Transgelin-2 Elevation Reduces MMP-9 Expression in Human Peripheral Blood Mononuclear Cells. In NEUROLOGY, 80 (Supplement), P05.147. 65th Annual Meeting of the American-Academy-of-Neurology (AAN), San Diego, CA, 16. März 2013 - 23. März 2013. (2013)